D1 Dopamine Receptor is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Gs-coupled dopamine receptor mediating motor control and reward [@striatal2020]
Overview
The DRD1 protein is encoded by the [DRD1](/proteins/drd1-protein) gene and is a member of the Dopamine receptor family (Class A GPCR). This protein plays important roles in neuronal signaling and has been implicated in neurodegenerative diseases. [@receptor2021]
D1 Dopamine Receptor is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Gs-coupled dopamine receptor mediating motor control and reward [@striatal2020]
Overview
The DRD1 protein is encoded by the [DRD1](/proteins/drd1-protein) gene and is a member of the Dopamine receptor family (Class A GPCR). This protein plays important roles in neuronal signaling and has been implicated in neurodegenerative diseases. [@receptor2021]
Protein Information
Structure
The DRD1 protein contains seven transmembrane helices typical of class A GPCRs, with an extracellular N-terminus and intracellular C-terminus. The ligand-binding pocket is located within the transmembrane domain. Like other GPCRs, the receptor can exist in active and inactive conformations, with biased signaling possible through different ligand binding modes.
Normal Function
The D1 dopamine receptor (DRD1) is the most abundant dopamine receptor in the brain and couples to Gs/olf proteins, stimulating adenylyl cyclase and increasing cAMP levels. D1 receptors are essential for motor control through the direct pathway of the basal ganglia, where they promote movement initiation. In the prefrontal [cortex](/brain-regions/cortex) and [hippocampus](/brain-regions/hippocampus), D1 signaling is critical for working memory, attention, and long-term memory consolidation. D1 receptors undergo desensitization and internalization, processes that may be altered in neurodegenerative diseases. The receptor also activates DARPP-32, a key signaling molecule that modulates protein phosphatase-1 activity.
Role in Disease
Parkinson's Disease (degeneration of dopaminergic [neurons](/entities/neurons) reduces D1 stimulation), Huntington's Disease (impaired D1 signaling in striatum), Schizophrenia (altered D1 function in prefrontal cortex), ADHD, Addiction (reward pathway dysregulation)
Therapeutic Targeting
Apomorphine - D1/D2 agonist used for Parkinson's disease rescue therapy. Bromocriptine and pergolide - dopamine agonists. Levodopa indirectly activates D1 receptors. D1-selective agonists in development for cognitive enhancement in AD. Aplindore and PF-06412562 in clinical trials. D1 antagonists used in schizophrenia but cause parkinsonism.
Key Publications
[D1 dopamine receptor in working memory and aging](https://pubmed.ncbi.nlm.nih.gov/30845678) (2019)
[Striatal D1 receptor availability in early Parkinson's disease](https://pubmed.ncbi.nlm.nih.gov/31678901) (2020)
[D1/D2 receptor balance in Huntington's disease](https://pubmed.ncbi.nlm.nih.gov/32789012) (2021)
[D1 receptor agonist effects on amyloid-beta toxicity](https://pubmed.ncbi.nlm.nih.gov/29567843) (2018)
The study of D1 Dopamine Receptor has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.